Metabolomics in the studies of islet autoimmunity and type 1 diabetes

Matej Orešič (Corresponding Author)

Research output: Contribution to journalArticleScientificpeer-review

13 Citations (Scopus)

Abstract

The metabolome is sensitive to genetic and environmental factors contributing to complex diseases such as type 1 diabetes (T1D). Metabolomics is the study of biochemical and physiological processes involving metabolites. It is therefore one of the key platforms for the discovery and study of pathophysiological phenomena leading to T1D and the development of T1D-associated complications. Although the application of metabolomics in T1D research is still rare, metabolomic research has already advanced across the full spectrum, from disease progression to the development of diabetic complications. Metabolomic studies in T1D have contributed to an improved etiopathogenic understanding and demonstrated their potential in the clinic. For example, metabolomic data from recent T1D studies suggest that a specific metabolic profile, or metabotype, precedes islet autoimmunity and the development of overt T1D. These early metabolic changes are attributed to many biochemical pathways, thus suggesting a systemic change in metabolism which may be inborn. Based on this evidence, the role of the metabolome in the progression to T1D is therefore to facilitate specific biochemical processes associated with T1D, and to contribute to the development of a vulnerable state in which disease is more likely to be triggered. This may have important implications for the understanding of T1D pathophysiology and early disease detection and prevention.
Original languageEnglish
Pages (from-to)236-247
JournalReview of Diabetic Studies
Volume9
Issue number4
DOIs
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Fingerprint

Metabolomics
Autoimmunity
Type 1 Diabetes Mellitus
Metabolome
Biochemical Phenomena
Diabetes Complications
Physiological Phenomena
Research
Disease Progression
Early Diagnosis

Keywords

  • allostasis
  • autoimmunity
  • biomarker
  • lipid metabolism
  • lipidomics
  • metabolomics
  • systems biology

Cite this

@article{99034deac7ca42669d5c2ed81bf04d68,
title = "Metabolomics in the studies of islet autoimmunity and type 1 diabetes",
abstract = "The metabolome is sensitive to genetic and environmental factors contributing to complex diseases such as type 1 diabetes (T1D). Metabolomics is the study of biochemical and physiological processes involving metabolites. It is therefore one of the key platforms for the discovery and study of pathophysiological phenomena leading to T1D and the development of T1D-associated complications. Although the application of metabolomics in T1D research is still rare, metabolomic research has already advanced across the full spectrum, from disease progression to the development of diabetic complications. Metabolomic studies in T1D have contributed to an improved etiopathogenic understanding and demonstrated their potential in the clinic. For example, metabolomic data from recent T1D studies suggest that a specific metabolic profile, or metabotype, precedes islet autoimmunity and the development of overt T1D. These early metabolic changes are attributed to many biochemical pathways, thus suggesting a systemic change in metabolism which may be inborn. Based on this evidence, the role of the metabolome in the progression to T1D is therefore to facilitate specific biochemical processes associated with T1D, and to contribute to the development of a vulnerable state in which disease is more likely to be triggered. This may have important implications for the understanding of T1D pathophysiology and early disease detection and prevention.",
keywords = "allostasis, autoimmunity, biomarker, lipid metabolism, lipidomics, metabolomics, systems biology",
author = "Matej Orešič",
year = "2012",
doi = "10.1900/RDS.2012.9.236",
language = "English",
volume = "9",
pages = "236--247",
journal = "Review of Diabetic Studies",
issn = "1613-6071",
publisher = "Society for Biomedical Diabetes Research",
number = "4",

}

Metabolomics in the studies of islet autoimmunity and type 1 diabetes. / Orešič, Matej (Corresponding Author).

In: Review of Diabetic Studies, Vol. 9, No. 4, 2012, p. 236-247.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Metabolomics in the studies of islet autoimmunity and type 1 diabetes

AU - Orešič, Matej

PY - 2012

Y1 - 2012

N2 - The metabolome is sensitive to genetic and environmental factors contributing to complex diseases such as type 1 diabetes (T1D). Metabolomics is the study of biochemical and physiological processes involving metabolites. It is therefore one of the key platforms for the discovery and study of pathophysiological phenomena leading to T1D and the development of T1D-associated complications. Although the application of metabolomics in T1D research is still rare, metabolomic research has already advanced across the full spectrum, from disease progression to the development of diabetic complications. Metabolomic studies in T1D have contributed to an improved etiopathogenic understanding and demonstrated their potential in the clinic. For example, metabolomic data from recent T1D studies suggest that a specific metabolic profile, or metabotype, precedes islet autoimmunity and the development of overt T1D. These early metabolic changes are attributed to many biochemical pathways, thus suggesting a systemic change in metabolism which may be inborn. Based on this evidence, the role of the metabolome in the progression to T1D is therefore to facilitate specific biochemical processes associated with T1D, and to contribute to the development of a vulnerable state in which disease is more likely to be triggered. This may have important implications for the understanding of T1D pathophysiology and early disease detection and prevention.

AB - The metabolome is sensitive to genetic and environmental factors contributing to complex diseases such as type 1 diabetes (T1D). Metabolomics is the study of biochemical and physiological processes involving metabolites. It is therefore one of the key platforms for the discovery and study of pathophysiological phenomena leading to T1D and the development of T1D-associated complications. Although the application of metabolomics in T1D research is still rare, metabolomic research has already advanced across the full spectrum, from disease progression to the development of diabetic complications. Metabolomic studies in T1D have contributed to an improved etiopathogenic understanding and demonstrated their potential in the clinic. For example, metabolomic data from recent T1D studies suggest that a specific metabolic profile, or metabotype, precedes islet autoimmunity and the development of overt T1D. These early metabolic changes are attributed to many biochemical pathways, thus suggesting a systemic change in metabolism which may be inborn. Based on this evidence, the role of the metabolome in the progression to T1D is therefore to facilitate specific biochemical processes associated with T1D, and to contribute to the development of a vulnerable state in which disease is more likely to be triggered. This may have important implications for the understanding of T1D pathophysiology and early disease detection and prevention.

KW - allostasis

KW - autoimmunity

KW - biomarker

KW - lipid metabolism

KW - lipidomics

KW - metabolomics

KW - systems biology

U2 - 10.1900/RDS.2012.9.236

DO - 10.1900/RDS.2012.9.236

M3 - Article

VL - 9

SP - 236

EP - 247

JO - Review of Diabetic Studies

JF - Review of Diabetic Studies

SN - 1613-6071

IS - 4

ER -